DARE Projected Dividend Yield
Dare Bioscience Inc ( NASDAQ : DARE )Dare Bioscience is a biopharmaceutical company. Co.'s product, XACIATO™ vaginal gel, is a single-dose prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. Co.'s portfolio includes three product candidates in clinical development: Ovaprene®, a hormone-free, monthly contraceptive; Sildenafil Cream, a proprietary cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder; and DARE-HRT1, a combination bio-identical estradiol and progesterone intravaginal ring, for the treatment of menopausal symptoms, including vasomotor symptoms, as part of hormone therapy following menopause. 20 YEAR PERFORMANCE RESULTS |
DARE Dividend History Detail DARE Dividend News DARE Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |